ArticleBlood advances2026

Prognostic value of inflammation-based scores in patients with R/R LBCL treated with CD3×CD20 bispecific T-cell engagers.

Giulia Magno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.